Angiotech Triumphs In Stent Patent Appeal

Law360, New York (March 15, 2007, 12:00 AM EDT) -- Marking the latest triumph for Angiotech Pharmaceuticals Inc. in its bid to protect its drug-coated coronary stent patent throughout Europe, the company on Thursday said the European Patent Office in Munich, Germany has denied a bid for an appeal by two rival medical device makers.

Angiotech said in a statement on Thursday that the EPO’s Technical Board of Appeal had rejected an attempt by Conor Medsystems Inc. and Sahajanand Medical Technologies Pvt. Ltd. to intervene and appeal an earlier decision by the EPO’s Opposition Division which...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.